Peer-reviewed. Press-covered. Award-winning.
From academic journals to national outlets, here is HCO's record of recognition across Health Care Originals, ADAMM, Nightingale Virtual Respiratory Care, and Imago Rehab.
2026
- AwardSuperCrowd / Purpose Built 100· Jul 7, 2026
Named to the Purpose Built 100
HCO recognized among the top 100 purpose-built companies, honoring mission-driven organizations building for long-term impact over short-term gain.
See the list - PressUSA Today· Jun 2026
The Future of Respiratory Care Is Proactive, Personalized, and Continuous
Sharon Samjitsingh writes for USA Today on why the future of respiratory care demands continuous physiological intelligence, not episodic checkups.
Read the article - PressFuture of Personal Health / Mediaplanet· Jun 2026
The Future of Respiratory Care Is Proactive, Personalized, and Continuous
Featured in Mediaplanet's Future of Personal Health publication, reaching readers through USA Today's national distribution network.
Read the article - AwardPenn State University· Jan 12, 2026
Dr. Jennifer Chambers, HCO CMO, named Penn State Distinguished Alumni Award recipient
Penn State's Board of Trustees selects Dr. Jennifer Chambers as one of ten recipients of the university's highest alumni honor for 2026, recognizing her decades of leadership in medicine and managed care, including her role as Chief Medical Officer of HCO and former CMO of Capital Blue Cross.
Read the announcement
2025
- JournalIJTLD Open / PubMed Central· Oct 10, 2025
Air pollution spikes measurably increase coughing in pulmonary fibrosis patients, ADAMM-RSM data shows
Ferrara et al. at the University of Alberta publish the first 6-month wearable-based study linking PM2.5 and ozone exposure to cough frequency in progressive pulmonary fibrosis. PM2.5 spikes correlate with cough increases 7-14 days later; ozone spikes trigger an acute response within 5 days. Data collected via ADAMM-RSM. Published in IJTLD Open, the journal of The International Union Against Tuberculosis and Lung Disease. (Vander Linden et al., IJTLD Open, 2025)
Read the paper - AnnouncementImago Rehab· Sep 2025
HCO acquires a majority stake in Imago Rehab
The deal brings Imago Rehab's clinician-led stroke tele-rehabilitation and its wearable soft-robotic rehab glove into the HCO portfolio, with the founders continuing to lead clinical work.
Learn more - AnnouncementAAFA· Sep 2025
HEAL Texas begins patient recruitment
The AAFA-led HEAL Texas pilot, built on HCO's Nightingale platform, opened recruitment for its IRB-approved study helping adults in Dallas–Fort Worth manage asthma.
Learn more - AnnouncementHealth Care Originals· Sep 2025
Community investment round closes near a $13M valuation
HCO wrapped its community raise, drawing retail investors alongside institutional backers reported to include Safar Partners, Cranberry Capital, and KingsCrowd Capital.
- JournalAmerican Journal of Medicine· Aug 2025
HCO Respiratory outcomes validated: 100% fewer symptoms, 67% zero attacks
Peer-reviewed publication in the American Journal of Medicine confirming HCO Respiratory's clinical outcomes, including 2x the American Thoracic Society efficacy threshold. First wearable respiratory solution to achieve this level of independent validation.
- JournalAmerican Journal of Medicine· Jul 2025
Cough intensity validated as first digital biomarker for pulmonary fibrosis progression
University of Alberta researchers use ADAMM-RSM to demonstrate that cough intensity is the first objectively measured digital biomarker correlated with disease progression in progressive pulmonary fibrosis. Cough intensity is a signal only ADAMM captures.
- PodcastNextCorps – Forward Faster· Jun 2025
Setting a New Standard in Respiratory Care
Sharon and Jared join NextCorps' Forward Faster podcast to discuss HCO's origins, the pivot from software to hardware, and what it took to build a company that puts clinical outcomes first.
Listen - AnnouncementLVBCH· Jun 3, 2025
LVBCH names HCO exclusive Preferred Partner for Virtual Respiratory Care
The Lehigh Valley Business Coalition on Healthcare, following an extensive review process, selects HCO as its exclusive virtual respiratory care provider for its 275+ employer members representing more than 400,000 lives. Preferred Partner status signals that HCO demonstrated superior outcomes, pricing, and service capabilities.
Read the announcement - AnnouncementAAFA· Apr 17, 2025
HEAL Texas launches with AAFA and Rabbit Air
The Asthma and Allergy Foundation of America launched HEAL Texas with HCO and Rabbit Air, pairing Nightingale with air purifiers and social-determinants support in Dallas–Fort Worth.
Learn more - PressForbes – ForbesWomen· Apr 2025
Reg CF Activates Asthma and COPD Care Investor Evangelists for HCO
Forbes covers HCO's Regulation Crowdfunding campaign, the AAFA HEAL partnership announcement, and CEO Sharon Samjitsingh's journey as a woman of color founder who received 350 investor rejections before building a company with signed payer contracts and validated outcomes.
Read the article - AnnouncementBusinessWire· Feb 25, 2025
HCO Named KingsCrowd "Top Deal" and Raises $1.6M Round
KingsCrowd, the leading research and analytics platform for private market deals, designates HCO a Top Deal with a 4.7/5.0 score. KingsCrowd Capital joins Safar Partners, Cranberry Capital, and Simon School Venture Fund in the round, with $1.6M raised from institutional and retail investors combined.
Read the announcement - PodcastSuperpowers for Good – Devin Thorpe· Jan 2, 2025
Health Care Originals Transforms Asthma Management with AI-Powered Wearable Technology
Sharon joins Devin Thorpe's Superpowers for Good, one of the leading impact investing and social entrepreneurship platforms, to discuss HCO's personal mission, technology, and the community of investors rallying around its campaign.
Watch the episode - AnnouncementHealth Care Originals· 2025
AIDAH agentic-AI system announced
HCO announced development of an agentic-AI system, AIDAH, to triage member data and scale respiratory therapist support, improving efficiency and unit economics.
2024
- PressChloe Capital· Nov 21, 2024
Chloe Capital portfolio spotlight: Health Care Originals
HCO investor Chloe Capital spotlights HCO as a portfolio company, describing it as the first asthma and COPD digital health solution and wearable to be validated by the Validation Institute, and highlighting the company's community crowdfunding campaign and path to becoming the leading platform in respiratory care.
Read the spotlight - AwardNBCOT· Oct 2024
Kristin Nuckols, HCO Neuro CCO, wins 2024 NBCOT Innovation Award
The National Board for Certification in Occupational Therapy spotlights Dr. Kristin Nuckols for her pioneering work combining robotics, telehealth, and neurologic rehabilitation. The NBCOT Innovation Award is the field's highest recognition for breakthrough work in occupational therapy.
Read the spotlight - AwardValidation Institute· Aug 21, 2024
HCO becomes the first respiratory program and first wearable ever independently validated for outcomes
The Validation Institute certifies HCO Respiratory's outcomes against actuarial standards, making HCO the first virtual respiratory care program and the first wearable device in any category to receive independent outcomes validation. The certification is backed by a $100,000 guarantee.
See the validation - AwardImago Rehab / ACRM· 2024
Imago Rehab wins ACRM LaunchPad ‘Best Overall’
Imago Rehab took the top prize at the American Congress of Rehabilitation Medicine LaunchPad competition for its soft-robotic, telehealth approach to stroke recovery.
Learn more
2023
- AnnouncementCityBiz / BusinessWire· Nov 2, 2023
Dr. Jennifer Chambers, former CMO of Capital Blue Cross, appointed HCO Chief Medical Officer
HCO welcomes Dr. Jennifer Chambers, MD, MBA, FACP, bringing decades of leadership in managed care, digital health strategy, and clinical medicine. Her appointment signals HCO's commitment to building a team with direct payer experience at the executive level.
Read the announcement - PressPatient Innovation· Nov 2023
HCO featured as a Patient Innovation solution for asthma and COPD
Patient Innovation, an international platform founded by Nova Medical School and Copenhagen Business School to connect patient-led healthcare solutions, features HCO's Nightingale wearable system as a recognized innovation for chronic respiratory disease.
See the feature
2021
- PressPulmonary Fibrosis News· Jul 12, 2021
University of Alberta launches study using ADAMM-RSM to predict IPF symptom worsening
Pulmonary Fibrosis News covers the University of Alberta's pilot study using ADAMM-RSM to monitor chronic lung conditions including IPF, cystic fibrosis, and post-transplant patients. The study – led by Dr. Giovanni Ferrara – explores whether continuous acoustic data can predict symptom worsening before a crisis, marking the beginning of a research partnership that would produce multiple published findings.
Read the article - AwardAmerican Heart Association – EmPOWERED to Serve· 2021
1st Place, National – AHA EmPOWERED to Serve Business Accelerator
Sharon Samjitsingh and HCO win first place in the American Heart Association's national EmPOWERED to Serve Business Accelerator, a program recognizing innovators whose work advances health equity and community health transformation across the United States.
See the finalists - AnnouncementImago Rehab / Harvard Innovation Labs· 2021
Imago Rehab founded out of Harvard
Imago Rehab launched as a virtual clinic pairing telehealth occupational therapy with a soft-robotic glove developed in Prof. Conor Walsh's lab, supported by Harvard Innovation Labs and MassChallenge.
Learn more
2020
- JournalJMIR mHealth and uHealth· May 2020
ADAMM ranked #1 in forecasting ability, ease of use, and appearance
UC San Diego researchers review and compare remote monitoring technologies for predicting COPD exacerbations. ADAMM ranks first across all three criteria: forecasting ability, ease of use, and appearance. (Fan et al., JMIR mHealth and uHealth, 2020)
- AwardTechRochester· 2020
CEO named TechRochester Technology Woman of the Year
Co-founder and CEO Sharon Samjitsingh was recognized as TechRochester's Technology Woman of the Year.
2019
- AwardWomen of Wearables· 2019
CEO named a Top 100 in FemTech & HealthTech
Women of Wearables named Sharon Samjitsingh among its Top 100 in FemTech and HealthTech.
2018
- AnnouncementCNW / Newswire· Dec 2018
Dr. Bradford Berk, former CEO of University of Rochester Medical Center, joins the HCO Board
Dr. Berk, Professor of Medicine and former CEO of URMC, brings decades of cardiology, pharmacology, and health system leadership to HCO's board as the company prepares its first commercial product launch.
Read the announcement - PressWearable Technologies· Nov 30, 2018
HCO announces Healthport partnership and new telemedicine product at MEDICA 2018
Wearable Technologies, the world's leading wearable innovation platform, covers HCO's appearance at MEDICA 2018 in Dusseldorf: the launch of its telemetry for telemedicine product and a new strategic alliance with Healthport, expanding HCO's reach into Australia and New Zealand.
Read the article - AnnouncementBioSpace· Aug 2018
Eric Allyn, former Chairman of Welch Allyn, joins the HCO Board
Eric Allyn, the former chairman of Welch Allyn (a $700M medical device company sold to Hill-Rom in 2015), joins HCO's board of directors. His early belief in HCO's platform has carried forward to his position as one of HCO's largest individual investors.
Read the announcement - SpeakingMedical Wearables Conference· 2018
Featured speaker at the Medical Wearables Conference
HCO selected as a featured speaker at the Medical Wearables Conference, presenting ADAMM's approach to continuous cardiopulmonary sensing and its implications for chronic disease management.
See the program - ResearchJefferson Health· 2018
ADAMM featured in clinical research at Jefferson Health
Coverage shifted toward clinical applications as researchers at Jefferson Health explored ADAMM for detecting conditions such as radiation pneumonitis.
2016
- AwardTechCrunch· May 2016
Breakthrough Innovation Award at TechCrunch Disrupt
HCO won the inaugural Breakthrough Innovation Award, presented by HP Tech Ventures, at the TechCrunch Disrupt Startup Battlefield in New York.
- AwardWearable Technologies· 2016
ADAMM wins the WT Innovation World Cup
ADAMM was named champion of the Healthcare & Wellness category at the Wearable Technologies Innovation World Cup, and HCO was named WT Innovator of the Year.
2015
- JournalJournal of Medical Internet Research· Oct 2015
ADAM device validity study: concurrent and predictive validity confirmed in adolescents with asthma
University of Rochester Medical Center researchers publish the foundational validity study for HCO's sensing technology, demonstrating the device's ability to accurately capture and predict asthma symptoms in real-world conditions. (Rhee et al., JMIR, 2015)
- AwardCES· 2015
CES 2015 Innovation Awards Honoree & ‘Best of CES’
ADAMM debuted at CES 2015 as an Innovation Awards Honoree and was featured on IndustryWeek's Best of CES 2015 list.
- AnnouncementHealth Care Originals· 2015
Health Care Originals founded
CEO Sharon Samjitsingh and COO Jared Dwarika founded HCO in Rochester, NY, to commercialize University of Rochester technology behind the ADAMM wearable.
Press resources
Members of the media can contact our communications team for interview requests, press materials, and additional information about Health Care Originals.
Media Contact
For press inquiries, interview requests, or additional information, please contact our communications team.
Email: press@healthcareoriginals.com
Phone: +1 (585) 471-8215
Want to learn more about HCO?
Discover how our programs are transforming chronic disease management.